DVA on XNYS, Health Care, DaVita Inc., job postings
Measures activity, not value. Not investment advice.
Twelve-month profit rose 19% to $920.1M, but insiders sold $69M in the last 90 days.
BadFederal contracts and grants: $235M over 12 months, down from $482.9M
Written by AI from the data on this page, 22 Nov 2026. Not investment advice.
Profile and fundamentals
From its SEC filings, 12 months to 30 Sep 2026
DaVita is one of the largest providers of dialysis services in the United States, boasting a market share of about 35%. The firm operates over 3,200 facilities worldwide, mostly in the US, and treats about 300,000 patients annually. Government payers dominate US dialysis reimbursement. DaVita receives about two-thirds of US sales at government (primarily Medicare) reimbursement rates, with the remainder coming from commercial insurers. While commercial insurers represent only about 10% of US patients treated, they represent nearly all of the profits generated by DaVita in the US dialysis business.
Industry
Services-misc health & allied services, nec (Health Care)
expected around 1 Feb 2027 (an estimate: a year ago it reported on 2 Feb 2026)
Revenue and net income per quarter. Quarter to 30 Sep 2026: revenue $3.6B, net income $222.9M.
31 Dec 2021RevenueNet incometallest bar $3.6B30 Sep 2026
See the numbers
Quarter to
Revenue
Net income
30 Sep 2026
$3.6B
$222.9M
30 Jun 2026
$3.6B
$265.4M
31 Mar 2026
$3.4B
$197.5M
31 Dec 2025
$3.6B
$234.2M
30 Sep 2025
$3.4B
$150.3M
30 Jun 2025
$3.4B
$199.3M
31 Mar 2025
$3.2B
$162.9M
31 Dec 2024
$3.3B
$259.3M
30 Sep 2024
$3.3B
$214.7M
30 Jun 2024
$3.2B
$222.7M
31 Mar 2024
$3.1B
$239.6M
31 Dec 2023
$3.1B
$150.7M
30 Sep 2023
$3.1B
$246.6M
30 Jun 2023
$3.0B
$178.7M
31 Mar 2023
$2.9B
$115.5M
31 Dec 2022
$2.9B
$68.1M
30 Sep 2022
$2.9B
$105.4M
30 Jun 2022
$2.9B
$224.8M
31 Mar 2022
$2.8B
$162.1M
31 Dec 2021
$2.9B
$187.5M
Fundamentals, 12 months to 30 Sep 2026
Measure
Latest
Year before
Peer median
RevenueiSales over the last 12 months reported.
$14.2B
$13.3B
Revenue growthiRevenue of the last 12 months compared with the 12 months before.
+6.4%
+3.8%
Net incomeiProfit after all costs and taxes over the last 12 months reported. Negative is a loss.
$920.1M
$771.9M
EPS (diluted)iEarnings per share: net income divided by the shares, counting options and convertibles. Left blank when the figures as filed do not fit today's share count (after a split).
$13.51
$9.69
Gross marginiWhat is left of each dollar of sales after the direct cost of making the product or service.
–
–
56.0%
Operating marginiOperating income as a share of sales: profit from the business before interest and taxes.
15.0%
15.4%
7.8%
Net marginiNet income as a share of sales: what the owners keep of each dollar sold.
6.5%
5.8%
5.8%
Return on equityiNet income of the last 12 months divided by shareholders' equity (the average of the latest balance sheet and the one a year earlier): the profit made on the owners' money.
–
-9.3%
Free cash flowiCash from operations minus capital spending over the last 12 months: cash the business produced.
$1.3B
$1.3B
CashiCash, cash equivalents and short-term investments on the latest balance sheet.
$566.3M
$736.5M
DebtiShort- and long-term borrowings on the latest balance sheet. Operating leases are not counted.
$10.8B
$10.2B
Net debtiDebt minus cash. Negative means the company holds more cash than it owes (net cash).
$10.2B
$9.5B
Debt to equityiDebt divided by shareholders' equity on the latest balance sheet: how much is borrowed for each dollar the owners have in the company. Blank when equity is negative.
–
0.06
Book value per shareiShareholders' equity (assets minus liabilities) on the latest balance sheet divided by the shares outstanding.
–
P/EiPrice to earnings: market cap divided by net income of the last 12 months. What investors pay for one dollar of yearly profit. Blank when the company made a loss.
11.0
24.7
P/SiPrice to sales: market cap divided by revenue of the last 12 months.
0.71
1.1
EV/SalesiEnterprise value (market cap plus debt minus cash) divided by revenue of the last 12 months.
1.4
1.2
P/BiPrice to book: market cap divided by shareholders' equity on the latest balance sheet. Blank when equity is negative.
–
4.1
Latest = 12 months to 30 Sep 2026; balance-sheet lines at its end. Peer median: companies in the same industry (SIC code), or the sector when the industry is small.
Peers nearest by market cap, its own industry first
Insider Buy/Sell iShares the company's insiders (directors, officers and owners of 10% or more) bought minus what they sold on the open market in the last 90 days, from their Form 4 filings.
-$69.0M
bought $0, sold $69.0M
Institutional holders iThe number of institutional investment managers (13F filers: funds, pensions, asset managers) reporting the stock, compared with the quarter before. 13F reports are public 45 days after quarter end and show long positions only.
+0.7%
618 13F filers vs 614
Institutional ownership iShares held by 13F filers at the latest quarter end, divided by the shares outstanding in the company's latest filing. Above 100% usually means a stale share count or double counting, and is marked.
96%
60.2M shares held by 13F filers (30 Sep 2026) of 62.9M outstanding (27 Oct 2026)
Short interest iShares sold short and not yet bought back, divided by the shares outstanding in the company's latest filing. From FINRA's latest short interest report: FINRA reports twice a month and publishes 7 business days after the settlement date. Above 100% means a stale share count, and is marked.
8.2%
5.1M shares sold short (30 Oct 2026) of 62.9M outstanding (27 Oct 2026)
Days to cover iShort interest divided by the stock's average daily trading volume, as FINRA publishes it: how many days of normal trading it would take short sellers to buy back every share. Latest report.
5.1
5.1M shares sold short (30 Oct 2026) divided by the stock's average daily volume, as FINRA publishes it
Short interest change iHow the number of shares sold short changed between FINRA's two latest reports, about two weeks apart.
+4.8%
4.9M shares sold short in the report before, 5.1M on 30 Oct 2026
Short sale volume iShare of the stock's latest daily volume on FINRA-reported off-exchange venues that was sold short. Market makers sell short routinely, so 40% to 50% is normal; compare it with the company's own 1-year average in the cell's details. A daily flow, not short interest.
66%
66% of off-exchange volume on 20 Nov 2026 was short sales; 1-year average 65%
Open jobs iJob postings open on the company's own careers site today, where we track it. Blank when we do not track this company's careers site yet.
3,381
Tracked since 21 Nov 2026
Open jobs change iHow the number of open job postings changed over the last 30 days: total hiring demand, any job, any country. Shown only once we have tracked the company for 30 days.
–
Tracking started 21 Nov 2026; the change shows after 30 days.
Employees iTotal staff the company reported in its latest annual report (10-K), with the change from the year before when both years are reported.
–
No headcount in its annual reports in our data.
Visa hiring (foreign workers) iApplications to hire foreign specialists on H-1B and E-3 visas certified by the Labor Department in the last 12 months, compared with the 12 months before. This is NOT total hiring: most hires need no visa. Open jobs shows total hiring where we track it.
-4.3%
67 vs 70 applications
Revenue growth iSales in the latest reported quarter compared with the same quarter a year earlier.
+4.6%
$3.6B vs $3.4B (quarter ended 30 Sep 2026)
Capital spending iMoney spent on buildings, machines and equipment in the latest quarter, compared with the same quarter a year earlier.
-4.0%
$159.5M vs $166.1M (quarter ended 30 Sep 2026)
Federal contracts iMoney the US government committed to the company in contracts and grants over the last 12 months.
$235.0M
the 12 months before: $482.9M
Lobbying iWhat the company reported spending on federal lobbying over the last four quarters.
$4.5M
4 quarters, $
Layoff notices iWorkers named in state WARN layoff notices over the last 12 months (employers must file them 60 days before a large layoff).
–
No data for this company
News (7d) iArticles about the company published in the last 7 days, from our Google News collection (one search per company, every half hour). Blank when we do not collect news for this company.
31
31 articles in the last 7 days; its usual week has 4.5 (the median of the 26 weeks before).
News vs usual iArticles in the last 7 days divided by the company's usual week: the median week of the 26 weeks before. Blank when the usual week has fewer than one article.
6.9×
31 articles in the last 7 days; its usual week has 4.5.
Price $161.03 on 20 Nov 2026, +40% over 12 months (12-month range $103.87 to $240.96)
Sharp change
8-K and other filings
Lobbying filing
Insider net buying (open market). Insiders sold a net $523.4M in the last 12 months (the 12 months before: -$628.8M).H-1B/E-3 applications certified. H-1B/E-3 applications certified: 67 published in the last 12 months, -4.3% on the 12 months before.Revenue per quarter. Revenue $3.6B in the latest quarter, +4.6% on a year earlier.Capital spending per quarter. Capital spending $159.5M in the latest quarter, -4.0% on a year earlier.Institutional holders (13F filers). 618 13F filers reported holding it in the latest 13F quarter, +18% on a year earlier.Federal obligations. Federal obligations: $127.6M published in the last 12 months, -78% on the 12 months before.Lobbying spend. Lobbying spend: $4.5M published in the last 12 months, -16% on the 12 months before.
Every point sits on the day the fact became public (filing acceptance or publication), not the day it happened; prices through 20 Nov 2026. Hover or tap a marker for the fact; click it for the evidence or the source. No data here for: workers in warn layoff notices.
Quarter ended 31 Dec 2021: $2.9B, +1.3% on a year earlier; public on 12 Feb 2022
Quarter ended 31 Mar 2022: $2.8B, -0.1% on a year earlier; public on 6 May 2022
Quarter ended 30 Jun 2022: $2.9B, +0.4% on a year earlier; public on 2 Aug 2022
Quarter ended 30 Sep 2022: $2.9B, +0.4% on a year earlier; public on 1 Nov 2022
Quarter ended 31 Dec 2022: $2.9B, -0.9% on a year earlier; public on 23 Feb 2023
Quarter ended 31 Mar 2023: $2.9B, +2.0% on a year earlier; public on 9 May 2023
Quarter ended 30 Jun 2023: $3.0B, +2.5% on a year earlier; public on 4 Aug 2023
Quarter ended 30 Sep 2023: $3.1B, +5.9% on a year earlier; public on 8 Nov 2023
Quarter ended 31 Dec 2023: $3.1B, +7.8% on a year earlier; public on 15 Feb 2024
Quarter ended 31 Mar 2024: $3.1B, +6.9% on a year earlier; public on 3 May 2024
Quarter ended 30 Jun 2024: $3.2B, +6.2% on a year earlier; public on 7 Aug 2024
Quarter ended 30 Sep 2024: $3.3B, +4.6% on a year earlier; public on 30 Oct 2024
Quarter ended 31 Dec 2024: $3.3B, +4.7% on a year earlier; public on 14 Feb 2025
Quarter ended 31 Mar 2025: $3.2B, +5.0% on a year earlier; public on 13 May 2025
Quarter ended 30 Jun 2025: $3.4B, +6.1% on a year earlier; public on 6 Aug 2025
Quarter ended 30 Sep 2025: $3.4B, +4.8% on a year earlier; public on 30 Oct 2025
Quarter ended 31 Dec 2025: $3.6B, +9.9% on a year earlier; public on 12 Feb 2026
Quarter ended 31 Mar 2026: $3.4B, +6.0% on a year earlier; public on 6 May 2026
Quarter ended 30 Jun 2026: $3.6B, +5.2% on a year earlier; public on 5 Aug 2026
Quarter ended 30 Sep 2026: $3.6B, +4.6% on a year earlier; public on 30 Oct 2026
Capital spending per quarter
Quarter ended 31 Dec 2021: $189.6M, -16% on a year earlier; public on 12 Feb 2022
Quarter ended 31 Mar 2022: $123.1M, -15% on a year earlier; public on 6 May 2022
Quarter ended 30 Jun 2022: $142.4M, -4.8% on a year earlier; public on 2 Aug 2022
Quarter ended 30 Sep 2022: $143.9M, -8.6% on a year earlier; public on 1 Nov 2022
Quarter ended 31 Dec 2022: $194.0M, +2.4% on a year earlier; public on 23 Feb 2023
Quarter ended 31 Mar 2023: $147.7M, +20% on a year earlier; public on 9 May 2023
Quarter ended 30 Jun 2023: $124.5M, -13% on a year earlier; public on 4 Aug 2023
Quarter ended 30 Sep 2023: $136.8M, -4.9% on a year earlier; public on 8 Nov 2023
Quarter ended 31 Dec 2023: $159.0M, -18% on a year earlier; public on 15 Feb 2024
Quarter ended 31 Mar 2024: $121.0M, -18% on a year earlier; public on 3 May 2024
Quarter ended 30 Jun 2024: $124.7M, +0.2% on a year earlier; public on 7 Aug 2024
Quarter ended 30 Sep 2024: $139.0M, +1.6% on a year earlier; public on 30 Oct 2024
Quarter ended 31 Dec 2024: $170.7M, +7.3% on a year earlier; public on 14 Feb 2025
Quarter ended 31 Mar 2025: $143.3M, +18% on a year earlier; public on 13 May 2025
Quarter ended 30 Jun 2025: $121.1M, -2.9% on a year earlier; public on 6 Aug 2025
Quarter ended 30 Sep 2025: $166.1M, +19% on a year earlier; public on 30 Oct 2025
Quarter ended 31 Dec 2025: $145.4M, -15% on a year earlier; public on 12 Feb 2026
Quarter ended 31 Mar 2026: $102.0M, -29% on a year earlier; public on 6 May 2026
Quarter ended 30 Jun 2026: $169.8M, +40% on a year earlier; public on 5 Aug 2026
Quarter ended 30 Sep 2026: $159.5M, -4.0% on a year earlier; public on 30 Oct 2026
Institutional holders (13F filers)
31 Dec 2021 report: 434; public on 14 Feb 2022
31 Mar 2022 report: 478; public on 16 May 2022
30 Jun 2022 report: 436; public on 15 Aug 2022
30 Sep 2022 report: 397; public on 14 Nov 2022
31 Dec 2022 report: 401; public on 14 Feb 2023
31 Mar 2023 report: 404; public on 15 May 2023
30 Jun 2023 report: 423; public on 14 Aug 2023
30 Sep 2023 report: 456; public on 14 Nov 2023
31 Dec 2023 report: 491; public on 14 Feb 2024
31 Mar 2024 report: 509; public on 15 May 2024
30 Jun 2024 report: 530; public on 14 Aug 2024
30 Sep 2024 report: 564; public on 14 Nov 2024
31 Dec 2024 report: 572; public on 14 Feb 2025
31 Mar 2025 report: 567; public on 15 May 2025
30 Jun 2025 report: 565; public on 14 Aug 2025
30 Sep 2025 report: 525; public on 14 Nov 2025
31 Dec 2025 report: 513; public on 17 Feb 2026
31 Mar 2026 report: 569; public on 15 May 2026
30 Jun 2026 report: 614; public on 14 Aug 2026
30 Sep 2026 report: 618; public on 16 Nov 2026
Federal obligations
Month from 1 Nov 2021: $0 published
Month from 1 Dec 2021: $725K published
Month from 1 Jan 2022: -$57K published
Month from 1 Mar 2022: $0 published
Month from 1 Apr 2022: $1.4M published
Month from 1 May 2022: $157K published
Month from 1 Jun 2022: -$27K published
Month from 1 Aug 2022: -$138K published
Month from 1 Sep 2022: -$61K published
Month from 1 Oct 2022: $281.4M published
Month from 1 Nov 2022: $572K published
Month from 1 Dec 2022: $339K published
Month from 1 Jan 2023: -$66K published
Month from 1 Feb 2023: -$84K published
Month from 1 Mar 2023: $933K published
Month from 1 Apr 2023: $0 published
Month from 1 May 2023: $135K published
Month from 1 Jun 2023: $43K published
Month from 1 Aug 2023: $143K published
Month from 1 Oct 2023: $250.6M published
Month from 1 Nov 2023: $915K published
Month from 1 Dec 2023: -$415K published
Month from 1 Jan 2024: -$54.6 published
Month from 1 Feb 2024: -$42K published
Month from 1 Mar 2024: -$133K published
Month from 1 Apr 2024: $550K published
Month from 1 May 2024: -$339K published
Month from 1 Jul 2024: $236K published
Month from 1 Oct 2024: $532K published
Month from 1 Nov 2024: $319K published
Month from 1 Dec 2024: $131.1M published
Month from 1 Jan 2025: $447K published
Month from 1 Feb 2025: $1.1M published
Month from 1 Mar 2025: $935K published
Month from 1 Apr 2025: $11.2M published
Month from 1 May 2025: $0 published
Month from 1 Jun 2025: $303.6M published
Month from 1 Aug 2025: $59.9M published
Month from 1 Sep 2025: $26.7M published
Month from 1 Oct 2025: $26.9M published
Month from 1 Nov 2025: $27.2M published
Month from 1 Dec 2025: $121.4M published
Month from 1 Feb 2026: $1.8M published
Month from 1 Mar 2026: $431K published
Month from 1 Apr 2026: $205K published
Month from 1 May 2026: $3.7M published
Month from 1 Jun 2026: $248K published
Month from 1 Jul 2026: $260K published
Month from 1 Aug 2026: -$14K published
Month from 1 Sep 2026: -$1.0M published
Month from 1 Oct 2026: $259K published
Month from 1 Nov 2026: $292K published
Lobbying spend
Quarter from 1 Jan 2022: $920K published
Quarter from 1 Apr 2022: $1.3M published
Quarter from 1 Jul 2022: $870K published
Quarter from 1 Oct 2022: $970K published
Quarter from 1 Jan 2023: $980K published
Quarter from 1 Apr 2023: $1.0M published
Quarter from 1 Jul 2023: $970K published
Quarter from 1 Oct 2023: $1.0M published
Quarter from 1 Jan 2024: $1.0M published
Quarter from 1 Apr 2024: $1.1M published
Quarter from 1 Jul 2024: $1.0M published
Quarter from 1 Jan 2025: $2.1M published
Quarter from 1 Apr 2025: $1.1M published
Quarter from 1 Jul 2025: $1.1M published
Quarter from 1 Oct 2025: $1.0M published
Quarter from 1 Jan 2026: $1.1M published
Quarter from 1 Apr 2026: $1.2M published
Quarter from 1 Jul 2026: $980K published
Quarter from 1 Oct 2026: $1.1M published
What is unusual now
Nothing unusual in the last 90 days: no change appeared. Its most unusual measure now is H-1B/E-3 applications certified at 10 (Aug 2026), 2.0× its normal month; higher than 93% of its own history.
3,381 open postings; careers site tracked since 21 Nov 2026. Most in Operations & administration 6%, Executive & administrative support 2%, Facilities & construction 1%, Sales & business development 1%.
Reported lobbying spend: $1.1M in Q3 2026, $980K in Q2 2026. Rows are lobbying firms hired or let go; amounts are reported per quarter, not per firm here.
Date
Change
Lobbying firm
Issue
Source
28 Apr 2025
New
Continental Strategy, LLCfor Davita, Inc.
Medicare and Medicaid reimbursement policies for specific kidney treatments.Health issues
Issues related to the Medicare Secondary Payer Act, including HR 6860 and S. 5018, Restore Protections for Dialysis Patients Act; Kidney Patient Access to Technologically Innovative and Essential Nephrology Treatments (PATIENT) Act, H.R. 5074/S. 4510; issues related to home dialysis.; Issues related to the National Dialysis Services Contracts.Medicare/Medicaid, VET
Two or more unrelated kinds of records unusual within 30 days
8 Oct 2019confirmed
Confirmed across sources Government contracts and Short interest and volume
DaVita(DVA): had 22.5M shares sold short in the 30 Aug 2019 report, 3.5× the same report last year, while it booked $150.8M in federal contract and grant obligations in September 2019, 2,554× the same month last year. Two unrelated kinds of activity within 28 days.
Short interest and volume: Short interest spike, became public on 12 Sep 2019
Short interest and volume: Short interest spike, became public on 25 Sep 2019
Government contracts: Federal obligations jump, became public on 6 Oct 2019
Short interest and volume: Short interest spike, became public on 10 Oct 2019
The 30 Aug 2019 report against the 24 reports before it.
this reportearliernormal: 5.2MSee the evidence (4 changes)
Short interest and volume: Short interest spike became public on 12 Sep 2019
DaVita had 22.5M shares sold short in the 30 Aug 2019 report, 3.5× the same report last year.
This period
22.5M (the 30 Aug 2019 report)
Normal report (median of 24 earlier)
5.2M
Typical spread (median absolute deviation)
921K
How far from its usual level
+12.7
Same report last year
6.4M
History used
609 days
the 30 Aug 2019 report24 earlier reportsnormal: 5.2M
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
Short interest and volume: Short interest spike became public on 25 Sep 2019
DaVita had 13.1M shares sold short in the 13 Sep 2019 report, 2.1× the same report last year.
This period
13.1M (the 13 Sep 2019 report)
Normal report (median of 24 earlier)
5.2M
Typical spread (median absolute deviation)
921K
How far from its usual level
+5.8
Same report last year
6.2M
History used
623 days
the 13 Sep 2019 report24 earlier reportsnormal: 5.2M
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
Government contracts: Federal obligations jump became public on 6 Oct 2019
DaVita booked $150.8M in federal contract and grant obligations in September 2019, 2,554× the same month last year.
This period
$150.8M (September 2019)
Normal month (median of 5 earlier)
$59K
Typical spread (median absolute deviation)
$62K
How far from its usual level
+150.7
Same month last year
$59K
History used
4,337 days
September 20195 earlier monthsnormal: $59K
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 9+ earlier periods, 365+ days of history and a value of at least $5.0M.
Short interest and volume: Short interest spike became public on 10 Oct 2019
DaVita had 10.9M shares sold short in the 30 Sep 2019 report, 2.1× the same report last year.
This period
10.9M (the 30 Sep 2019 report)
Normal report (median of 24 earlier)
5.2M
Typical spread (median absolute deviation)
921K
How far from its usual level
+4.2
Same report last year
5.3M
History used
640 days
the 30 Sep 2019 report24 earlier reportsnormal: 5.2M
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
Several things at once means two or more unrelated kinds of records changed sharply within 30 days. Records that come from the same documents (for example filings and the financials taken from them) count as one kind.
Timeline
Changes and notable records, by the date each became public
saw 106 13F filers open a new position in the quarter ended 31 Mar 2026, 1.5× the same quarter last year.
Same quarter last year: 73; its normal quarter is 60.5.
See the evidence
This period
106 (the quarter ended 31 Mar 2026)
Normal quarter (median of 8 earlier)
60.5
Typical spread (median absolute deviation)
8
How far from its usual level
+3.8
Same quarter last year
73
History used
4,565 days
the quarter ended 31 Mar 20268 earlier quartersnormal: 60.5
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 6+ earlier periods, 730+ days of history and a value of at least 20.
booked $121.4M in federal contract and grant obligations in December 2025, 7.4% below the same month last year.
Same month last year: $131.1M; its normal month is $0.
See the evidence
This period
$121.4M (December 2025)
Normal month (median of 5 earlier)
$0
Typical spread (median absolute deviation)
$204K
How far from its usual level
+121.4
Same month last year
$131.1M
History used
6,621 days
December 20255 earlier monthsnormal: $0
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 9+ earlier periods, 365+ days of history and a value of at least $5.0M.
booked $27.2M in federal contract and grant obligations in November 2025, 85× the same month last year.
Same month last year: $319K; its normal month is $704K.
See the evidence
This period
$27.2M (November 2025)
Normal month (median of 5 earlier)
$704K
Typical spread (median absolute deviation)
$166K
How far from its usual level
+26.5
Same month last year
$319K
History used
6,590 days
November 20255 earlier monthsnormal: $704K
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 9+ earlier periods, 365+ days of history and a value of at least $5.0M.
booked $26.9M in federal contract and grant obligations in October 2025, 28× the same month last year.
Same month last year: $968K; its normal month is $621K.
See the evidence
This period
$26.9M (October 2025)
Normal month (median of 5 earlier)
$621K
Typical spread (median absolute deviation)
$128K
How far from its usual level
+26.2
Same month last year
$968K
History used
1,856 days
October 20255 earlier monthsnormal: $621K
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 9+ earlier periods, 365+ days of history and a value of at least $5.0M.
booked $26.2M in federal contract and grant obligations in August 2025, against none in the same month last year.
See the evidence
This period
$26.2M (August 2025)
Normal month (median of 5 earlier)
$0
Typical spread (median absolute deviation)
$118K
How far from its usual level
+26.2
Same month last year
$0
History used
6,499 days
August 20255 earlier monthsnormal: $0
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 9+ earlier periods, 365+ days of history and a value of at least $5.0M.
booked $33.7M in federal contract and grant obligations in July 2025, against none in the same month last year.
See the evidence
This period
$33.7M (July 2025)
Normal month (median of 4 earlier)
$2K
Typical spread (median absolute deviation)
$2K
How far from its usual level
+33.7
Same month last year
$0
History used
1,764 days
July 20254 earlier monthsnormal: $2K
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 9+ earlier periods, 365+ days of history and a value of at least $5.0M.
booked $303.6M in federal contract and grant obligations in June 2025, against none in the same month last year.
See the evidence
This period
$303.6M (June 2025)
Normal month (median of 5 earlier)
$43K
Typical spread (median absolute deviation)
$70K
How far from its usual level
+303.6
Same month last year
$0
History used
6,437 days
June 20255 earlier monthsnormal: $43K
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 9+ earlier periods, 365+ days of history and a value of at least $5.0M.
booked $12.1M in federal contract and grant obligations in March 2025, 20× the same month last year.
Same month last year: $593K; its normal month is $933K.
See the evidence
This period
$12.1M (March 2025)
Normal month (median of 5 earlier)
$933K
Typical spread (median absolute deviation)
$316K
How far from its usual level
+11.2
Same month last year
$593K
History used
6,346 days
March 20255 earlier monthsnormal: $933K
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 9+ earlier periods, 365+ days of history and a value of at least $5.0M.
booked $131.1M in federal contract and grant obligations in December 2024, against a normal month of -$47K.
Same month a year earlier: -$204K.
See the evidence
This period
$131.1M (December 2024)
Normal month (median of 5 earlier)
-$47K
Typical spread (median absolute deviation)
$47K
How far from its usual level
+131.1
Same month last year
-$204K
History used
6,256 days
December 20245 earlier monthsnormal: -$47K
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 9+ earlier periods, 365+ days of history and a value of at least $5.0M.
had 5.0M shares sold short in the 31 Jan 2024 report, 1.8× the same report last year.
Same report last year: 2.7M; its normal report is 3.0M.
See the evidence
This period
5.0M (the 31 Jan 2024 report)
Normal report (median of 24 earlier)
3.0M
Typical spread (median absolute deviation)
348K
How far from its usual level
+3.9
Same report last year
2.7M
History used
2,224 days
the 31 Jan 2024 report24 earlier reportsnormal: 3.0M
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
had 5.9M shares sold short in the 12 Jan 2024 report, 2.1× the same report last year.
Same report last year: 2.8M; its normal report is 3.0M.
See the evidence
This period
5.9M (the 12 Jan 2024 report)
Normal report (median of 24 earlier)
3.0M
Typical spread (median absolute deviation)
297K
How far from its usual level
+6.6
Same report last year
2.8M
History used
2,205 days
the 12 Jan 2024 report24 earlier reportsnormal: 3.0M
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
had 5.4M shares sold short in the 29 Dec 2023 report, 2.1× the same report last year.
Same report last year: 2.6M; its normal report is 2.9M.
See the evidence
This period
5.4M (the 29 Dec 2023 report)
Normal report (median of 24 earlier)
2.9M
Typical spread (median absolute deviation)
276K
How far from its usual level
+6.1
Same report last year
2.6M
History used
2,191 days
the 29 Dec 2023 report24 earlier reportsnormal: 2.9M
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
had 6.0M shares sold short in the 15 Dec 2023 report, 2.2× the same report last year.
Same report last year: 2.7M; its normal report is 2.9M.
See the evidence
This period
6.0M (the 15 Dec 2023 report)
Normal report (median of 24 earlier)
2.9M
Typical spread (median absolute deviation)
195K
How far from its usual level
+10.7
Same report last year
2.7M
History used
2,177 days
the 15 Dec 2023 report24 earlier reportsnormal: 2.9M
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
had 6.4M shares sold short in the 30 Nov 2023 report, 2.1× the same report last year.
Same report last year: 3.1M; its normal report is 2.9M.
See the evidence
This period
6.4M (the 30 Nov 2023 report)
Normal report (median of 24 earlier)
2.9M
Typical spread (median absolute deviation)
182K
How far from its usual level
+12.3
Same report last year
3.1M
History used
2,162 days
the 30 Nov 2023 report24 earlier reportsnormal: 2.9M
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
had 6.7M shares sold short in the 15 Nov 2023 report, 2.2× the same report last year.
Same report last year: 3.1M; its normal report is 2.9M.
See the evidence
This period
6.7M (the 15 Nov 2023 report)
Normal report (median of 24 earlier)
2.9M
Typical spread (median absolute deviation)
182K
How far from its usual level
+13.5
Same report last year
3.1M
History used
2,147 days
the 15 Nov 2023 report24 earlier reportsnormal: 2.9M
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
had 5.1M shares sold short in the 31 Oct 2023 report, 1.4× the same report last year.
Same report last year: 3.6M; its normal report is 2.9M.
See the evidence
This period
5.1M (the 31 Oct 2023 report)
Normal report (median of 24 earlier)
2.9M
Typical spread (median absolute deviation)
182K
How far from its usual level
+8.0
Same report last year
3.6M
History used
2,132 days
the 31 Oct 2023 report24 earlier reportsnormal: 2.9M
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
Showing the newest 40 of 161 entries; narrow the window or the kind of data to see older ones.
Not listed: 240 routine records (quarterly and annual reports, results releases, other 8-K items, material agreements and individual insider sales), counted over all history.
Identifiers and sources
How records are matched to this company, and what each source holds for it
Cik
0000927066
Ticker
DVA
Domain
davita.com
Employer name
DaVita, Inc. (1 unverified)
Hq location
CO|DENVER|80202 (1 unverified)
Lobbying client
davita, davita healthcare partners, jefferson business consulting on behalf of davita
Name
Aberdeen Dialysis, LLC, Adair Dialysis, LLC, Afton Dialysis, LLC, Ahern Dialysis, LLC and 731 more
Uei
PCJQZRE36Z73
Wikidata
Q5207184
Wikipedia
DaVita
DOL H-1B labor condition applications and PERM certifications1354 data points7 Oct 2019 to 28 Sep 2026
Federal lobbying disclosures (LDA)57 records, 243 data points30 Dec 1899 to 30 Sep 2026
SEC Form 13F institutional holdings2 records, 481 data points30 Jun 2013 to 30 Sep 2026
SEC EDGAR filings (8-K items, S-1, Form D, 10-K/10-Q)166 records11 Feb 2016 to 29 Oct 2026
SEC XBRL company facts (revenue, capex, R&D, backlog...)1085 data points31 Dec 2006 to 27 Oct 2026
SEC Form 4 insider transactions108 records, 340 data points18 Feb 2016 to 29 Oct 2026
FINRA short interest (twice monthly)624 data points29 Dec 2017 to 30 Oct 2026
FINRA daily short sale volume (off-exchange)4178 data points1 Aug 2018 to 20 Nov 2026
USASpending.gov federal awards37 records, 1063 data points15 Nov 2007 to 3 Nov 2026
Wikipedia pageviews2881 data points1 Jan 2019 to 21 Nov 2026